Dr. Aurélien Delluc, M.D. Ph. D.
Claim this profileThe Ottawa Hospital - Ottawa Hospital Research Institute (OHRI)
Studies Intrapericardial Thrombosis
Studies Blood Clot
3 reported clinical trials
6 drugs studied
Clinical Trials Aurélien Delluc, M.D. Ph. D. is currently running
Statins
for Blood Clots
The standard or usual treatment for patients diagnosed with deep vein thrombosis or pulmonary embolism is treatment with blood thinners (called anticoagulants). While treatment of blood clots with blood thinners is effective, some research has shown that adding a statin (medication used to lower cholesterol) may give extra protection. It is thought that statins can improve how cells along the walls of the vein control inflammation, which can prevent new blood clots from forming. The medication in this study, rosuvastatin, is approved in Canada for use as a cholesterol-lowering medication. The use of rosuvastatin in this study is considered investigational. This means that Health Canada has not approved the use of rosuvastatin as a treatment for blood clots. However, it has been approved for use in this research study. The purpose of this study is to examine if adding a statin (rosuvastatin) to the usual blood thinner treatment will decrease the risk of another blood clot forming. The investigators also hope to discover if taking a statin reduces damage to your veins. To do this, some of the participants in this study will get rosuvastatin and others will receive a placebo (a substance that looks like the study rosuvastatin but does not have any active or medicinal ingredients). The placebo in this study is not intended to have any effect on your blood clot. A placebo is used to make the results of the study more reliable.
Recruiting1 award Phase 31 criteria
Cancer Screening
for Blood Clots
This trial is testing if using a special imaging test called FDG-PET/CT can better detect hidden cancers in patients who have had their first unprovoked blood clot. The test works by using a sugary dye that cancer cells absorb, making them visible on the scan. The goal is to see if this method finds more hidden cancers compared to standard screening.
Recruiting1 award N/A6 criteria
More about Aurélien Delluc, M.D. Ph. D.
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Aurélien Delluc, M.D. Ph. D. has experience with
- Placebo Oral Tablet
- Rosuvastatin Calcium
- Rivaroxaban
- Tinzaparin
- Limited Cancer Screening
- Limited Cancer Screening + FDG PET/CT
Breakdown of trials Aurélien Delluc, M.D. Ph. D. has run
Intrapericardial Thrombosis
Blood Clot
Arterial Thromboembolic Disease
Venous Thromboembolism
Venous Stasis Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aurélien Delluc, M.D. Ph. D. specialize in?
Aurélien Delluc, M.D. Ph. D. focuses on Intrapericardial Thrombosis and Blood Clot. In particular, much of their work with Intrapericardial Thrombosis has involved treating patients, or patients who are undergoing treatment.
Is Aurélien Delluc, M.D. Ph. D. currently recruiting for clinical trials?
Yes, Aurélien Delluc, M.D. Ph. D. is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Aurélien Delluc, M.D. Ph. D. has studied deeply?
Yes, Aurélien Delluc, M.D. Ph. D. has studied treatments such as Placebo Oral Tablet, Rosuvastatin Calcium, Rivaroxaban.
What is the best way to schedule an appointment with Aurélien Delluc, M.D. Ph. D.?
Apply for one of the trials that Aurélien Delluc, M.D. Ph. D. is conducting.
What is the office address of Aurélien Delluc, M.D. Ph. D.?
The office of Aurélien Delluc, M.D. Ph. D. is located at: The Ottawa Hospital - Ottawa Hospital Research Institute (OHRI), Ottawa, Ontario Canada. This is the address for their practice at the The Ottawa Hospital - Ottawa Hospital Research Institute (OHRI).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.